X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1369) 1369
Publication (102) 102
Newsletter (27) 27
Book Review (23) 23
Book Chapter (19) 19
Magazine Article (4) 4
Conference Proceeding (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dextromethorphan (885) 885
humans (861) 861
male (631) 631
pharmacology & pharmacy (568) 568
female (480) 480
index medicus (423) 423
animals (356) 356
dextromethorphan - therapeutic use (349) 349
adult (338) 338
middle aged (245) 245
rats (230) 230
dextromethorphan - pharmacology (206) 206
neurosciences (185) 185
dose-response relationship, drug (149) 149
dextromethorphan - administration & dosage (142) 142
double-blind method (141) 141
pharmacokinetics (134) 134
clinical neurology (133) 133
cytochrome p-450 cyp2d6 - metabolism (132) 132
dextromethorphan - pharmacokinetics (131) 131
phenotype (122) 122
aged (120) 120
receptors, n-methyl-d-aspartate - antagonists & inhibitors (120) 120
antitussive agents - therapeutic use (115) 115
drug interactions (115) 115
adolescent (113) 113
dextrorphan (112) 112
metabolism (112) 112
dextromethorphan - adverse effects (111) 111
dextromethorphan - metabolism (110) 110
analysis (107) 107
cough - drug therapy (106) 106
cyp2d6 (106) 106
excitatory amino acid antagonists - therapeutic use (105) 105
cytochrome p-450 cyp2d6 - genetics (104) 104
cytochrome p-450 (102) 102
rats, sprague-dawley (98) 98
morphine (96) 96
child (93) 93
cytochrome p-450 enzyme system - metabolism (91) 91
psychiatry (90) 90
ketamine (85) 85
genotype (84) 84
treatment outcome (84) 84
mice (81) 81
administration, oral (78) 78
drug combinations (78) 78
pharmacology/toxicology (78) 78
research (77) 77
pediatrics (76) 76
anesthesiology (74) 74
child, preschool (74) 74
toxicology (72) 72
pain (71) 71
pharmacology (71) 71
inhibition (70) 70
health aspects (69) 69
drugs (68) 68
young adult (68) 68
metabolites (67) 67
rat (67) 67
time factors (67) 67
excitatory amino acid antagonists - pharmacology (66) 66
brain (65) 65
in-vitro (65) 65
care and treatment (64) 64
stimulants (64) 64
analgesics, opioid - therapeutic use (63) 63
medicine & public health (63) 63
chemistry, analytical (62) 62
cytochrome p450 (61) 61
double-blind (61) 61
drug therapy (61) 61
drug therapy, combination (61) 61
methyl aspartate (59) 59
dextromethorphan - urine (58) 58
hydroxylation (58) 58
infant (57) 57
dextromethorphan - blood (55) 55
children (54) 54
enzymes (54) 54
pain - drug therapy (54) 54
pain measurement (54) 54
physiological aspects (54) 54
kinetics (53) 53
medicine, general & internal (53) 53
neuropathic pain (52) 52
antitussive agents - adverse effects (51) 51
cough (50) 50
cross-over studies (50) 50
debrisoquine (49) 49
quinidine - therapeutic use (49) 49
analgesia (48) 48
biomedicine (48) 48
glutamate (48) 48
quinidine (48) 48
chromatography, high pressure liquid (46) 46
in-vivo (46) 46
reproducibility of results (46) 46
article (45) 45
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1397) 1397
Japanese (8) 8
Spanish (5) 5
German (3) 3
Finnish (1) 1
French (1) 1
Hebrew (1) 1
Italian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Current Neuropharmacology, ISSN 1570-159X, 01/2017, Volume 15, Issue 1, pp. 57 - 70
Current pharmacotherapies for major depressive disorder (MDD) have a distinct lag of onset that can prolong distress and impairment for patients, and realworld... 
α-amino-3-hydroxyl-5-methyl-4-isoxazoleproprionic acid (AMPA) | Negative allosteric modulator | Major depressive disorder (MDD) | Metabotropic | N-methyl-D-aspartate (NMDA) | Positive allosteric modulator | Antagonist | Glutamate | negative allosteric modulator | RECEIVING HOSPICE CARE | TREATMENT-RESISTANT DEPRESSION | ADD-ON TRIAL | D-ASPARTATE ANTAGONIST | RANDOMIZED CONTROLLED-TRIAL | antagonist | metabotropic | NEUROSCIENCES | major depressive disorder (MDD) | SITE PARTIAL AGONIST | ANTIDEPRESSANT-LIKE ACTIVITY | PROOF-OF-CONCEPT | alpha-amino-3-hydroxyl-5-methyl-4-isoxazoleproprionic acid (AMPA) | LOW-DOSE KETAMINE | PHARMACOLOGY & PHARMACY | glutamate | positive allosteric modulator | RAPID-ACTING ANTIDEPRESSANT | Antidepressive Agents - therapeutic use | Receptors, Glutamate - metabolism | Animals | Excitatory Amino Acid Agents - therapeutic use | Depressive Disorder, Major - metabolism | Humans | Excitatory Amino Acid Agents - pharmacology | Antidepressive Agents - pharmacology | Depressive Disorder, Major - drug therapy | Dopamine | Abuse | Glutamic acid receptors (ionotropic) | Oral administration | Central nervous system | Clinical trials | N-Methyl-D-aspartic acid receptors | Dextromethorphan | Glutamic acid receptors | Mental depression | Glycine | Drug development | Cycloserine | Neuromodulation | Allosteric properties | Memantine | Ketamine | α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid | Antagonist drugs | Antidepressants | Norepinephrine | Drug therapy | Glutamic acid receptors (metabotropic)
Journal Article
Minerva Anestesiologica, ISSN 0375-9393, 10/2010, Volume 76, Issue 10, pp. 805 - 813
Background. Despite many one- or two-modal attempts to relieve postoperative nausea and vomiting (PONV) and pain, postoperative issues following breast cancer... 
Anaesthesia recovery period | Pain | Postoperative nausea and vomiting | MASTECTOMY | AMBULATORY ANESTHESIA | PLACEBO | MANAGEMENT | EFFICACY | ONDANSETRON | PROPOFOL | DEXTROMETHORPHAN | NSAIDS | ANESTHESIOLOGY | POSTOPERATIVE PAIN | CRITICAL CARE MEDICINE | Acetaminophen - adverse effects | Dextromethorphan - therapeutic use | Pyrazoles - therapeutic use | Humans | Middle Aged | Acetaminophen - administration & dosage | Antiemetics - administration & dosage | Dexamethasone - adverse effects | Narcotics - therapeutic use | Amines - therapeutic use | Antiemetics - adverse effects | gamma-Aminobutyric Acid - adverse effects | Dexamethasone - administration & dosage | Cyclohexanecarboxylic Acids - administration & dosage | Combined Modality Therapy | Dexamethasone - therapeutic use | Ondansetron - therapeutic use | Nervous System Diseases - chemically induced | Ondansetron - adverse effects | Sulfonamides - administration & dosage | Dextromethorphan - administration & dosage | Lymph Node Excision | Pain, Postoperative - etiology | Breast Neoplasms - surgery | Fentanyl | gamma-Aminobutyric Acid - administration & dosage | Anesthesia, Intravenous | Preanesthetic Medication | Narcotics - adverse effects | Analgesics, Non-Narcotic - adverse effects | Antiemetics - therapeutic use | Amines - administration & dosage | Mastectomy | Female | Amines - adverse effects | gamma-Aminobutyric Acid - therapeutic use | Acetaminophen - therapeutic use | Dextromethorphan - adverse effects | Pyrazoles - adverse effects | Cyclohexanecarboxylic Acids - therapeutic use | Cyclohexanecarboxylic Acids - adverse effects | Ondansetron - administration & dosage | Analgesics, Non-Narcotic - administration & dosage | Analgesics, Non-Narcotic - therapeutic use | Celecoxib | Postoperative Nausea and Vomiting - prevention & control | Pain, Postoperative - prevention & control | Pilot Projects | Pyrazoles - administration & dosage | Sulfonamides - therapeutic use | Intraoperative Care | Anesthesia Recovery Period | Sulfonamides - adverse effects | Aged | Sentinel Lymph Node Biopsy | Postoperative Nausea and Vomiting - etiology | Morphine - adverse effects | Morphine - therapeutic use
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 11/2012, Volume 36, Issue 9, pp. 3224 - 3234
Amantadine and dextromethorphan suppress levodopa (L-DOPA)-induced dyskinesia (LID) in patients with Parkinsons disease (PD) and abnormal involuntary movements... 
6-hydroxydopamine | Parkinson's disease | Serotonin | L-DOPA | Dyskinesia | DOPA-INDUCED DYSKINESIA | LEVODOPA-INDUCED DYSKINESIAS | ABNORMAL INVOLUNTARY MOVEMENTS | dyskinesia | SUBSTANTIA-NIGRA | NEUROSCIENCES | serotonin | IN-VIVO | MOTOR | EXPRESSION | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED PRIMATES | RODENT MODEL | AGONIST | Dextromethorphan - therapeutic use | Dyskinesias - drug therapy | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Rats, Wistar | Levodopa - therapeutic use | Dyskinesias - physiopathology | Rats | Male | Parkinsonian Disorders - chemically induced | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Dopamine Agents - therapeutic use | Oxidopamine | Amantadine - therapeutic use | Piperazines - pharmacology | Rats, Sprague-Dawley | Antiparkinson Agents - therapeutic use | Receptor, Serotonin, 5-HT1A - drug effects | Serotonin 5-HT1 Receptor Antagonists - therapeutic use | Animals | Parkinsonian Disorders - drug therapy | Receptors, N-Methyl-D-Aspartate - agonists | Cycloserine - pharmacology | Pyridines - pharmacology | Methyl aspartate | Neurosciences | Dopa | Drugs | Amantadine | Animal models | sensorimotor system | Neurodegenerative diseases | Glutamic acid receptors (ionotropic) | 6-Hydroxydopamine | Data processing | N-Methyl-D-aspartic acid receptors | Dextromethorphan | Cycloserine | Serotonin S1 receptors | Antagonism | Levodopa | N-Methyl-D-aspartic acid | Movement disorders
Journal Article
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 07/2015, Volume 16, Issue 11, pp. 1649 - 1656
Journal Article
British Journal of Anaesthesia, ISSN 0007-0912, 08/2019, Volume 123, Issue 2, pp. e397 - e411
Journal Article